3 Earnings to Watch Next Week
The show must go on for Wall Street.
Mike Sakuraba graduated with double major of English and Economics. Part time writer, part time investor, full time dad. Mike loves writing about technology, sports, and investing.
2022-10-29 11:59

3 More Earnings I’m Watching Next Week
Oh boy, it was certainly a rough week for tech stocks. Nearly every mega-cap company tumbled following a major miss on their third-quarter earnings. Meta Platforms ($186.06|-0.25%) fell by 25% and Amazon ($102.18|-1.17%) dropped by 13%. Alphabet ($102.9|-1.79%) and Microsoft ($256.77|-0.61%) didn’t fare much better. Has the market reached a new bottom? It’s hard to say. It could lead to the Fed deciding to pivot sooner, or at least slow the pace of its rate hikes.
3 Earnings to Watch Next Week
But either way, the show must go on for Wall Street. As critical as these companies are, there are around 495 others in the S&P 500. The market is not defined by these five stocks and neither should your portfolio. Here’s a look at three companies that I’ll be watching for next week when they report their earnings.

What was a semiconductor darling earlier in the year has quickly turned into a pumpkin during the past few months. AMD provided an early preview of third-quarter earnings and the company announced it is anticipating a decline in earnings. The stock has been punished and is down by 61% this year, and 14.3% over the past month. AMD has also been hit with a broader decline in semiconductor demand, particularly in the gaming and computer industries. Finally, new export restrictions to China have put a sour note on the entire semiconductor industry as the proverbial cherry on top. We know AMD Is going to decline this quarter, they already said as much. But I’ll be listening for when the company believes consumer demand will return. Until then, AMD’s stock seems destined to keep seeing weakness.

I don’t often write about biotech stocks because frankly, I don’t really understand the industry as well as others. But that doesn’t mean I don’t follow the stocks. Amgen has surprised me this year with its strong performance. It turns out that prescription medications are a recession-proof industry, and Amgen is far out-performing the broader markets this year. Amgen recently received FDA approval for a lung cancer drug that some analysts believe could be a game changer. It is believed that it could bring in billions of dollars in revenue as early as next year. I don’t know much about the sector, but Amgen has my attention.

Last quarter I wanted to watch to see how Airbnb did as global travel opens back up. Since then there has been a lot of grumbling on the internet about the high costs of booking an Airbnb. It seems that Airbnb hosts are trying to make up for lost time after missing out on two years during the pandemic. Still, the stock suffered, which was a puzzling reaction. This quarter, I want to hear about how Airbnb is approaching a sentiment shift back to hotels. Will it see a decline in revenues due to the higher charges from hosts? We are all keen to travel, but I suspect that like airline tickets, Airbnbs will be expensive for quite some time. And this could eat into Airbnb’s bottom line.

Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

Published On
2022-10-29 11:59

About the Author
Mike Sakuraba graduated with double major of English and Economics. Part time writer, part time investor, full time dad. Mike loves writing about technology, sports, and investing.

You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

AI-mazing returns: The top 3 AI stocks to invest in now!
Don't miss out on the opportunity to invest in these cutting-edge companies and be a part of the future of AI.
By Staff | 2 weeks ago

Goldman Sachs Trims the Fat with 3,200 Job Cuts
Goldman Sachs is cutting approximately 3,200 jobs from its core banking and trading units.
By Staff | 4 weeks ago

Tilray Q2 Earnings Leave Investors Wanting More
While Tilray has maintained its leading market share in the recreational cannabis market in Canada and the medical cannabis market in Europe, its Q2 earnings, which included a loss per share of -$0.11 and an adjusted loss per share of -$0.06, have left investors questioning the company's future growth prospects.
By Staff | 4 weeks ago

Qualcomm's partnership with Iridium takes connectivity to new heights
Qualcomm's partnership with Iridium brings satellite-based messaging technology to phones, laptops and other devices, providing new opportunities for connectivity in any location.
By Staff | 4 weeks ago

Hologic's Fiscal Q1 2023 Earnings: A Ray of Hope in a Stormy Year
Hologic has managed to achieve impressive financial results in Fiscal Q1 2023.
By Staff | 4 weeks ago

Why Small and Mid-Cap Stocks Deserve Your Attention
Why valuations make small and mid-cap stocks an attractive option in a potential recession.
By Staff | 4 weeks ago

Get Ready for a Bumpy Year
Despite strong job creation numbers, deeper issues lurk beneath the surface as the Federal Reserve's rate hikes and high inflation threaten to derail the economy.
By Staff | 4 weeks ago